Celyad Oncology (CYAD.BR) traded up 7.69 % during a 24 hours period ending at 04:18 PM Central Europe on Monday 26th. One Celyad Oncology stock can currently be bought for about EUR 0.21 on popular exchanges. Current supply of Celyad Oncology stocks is 74.9 mn. Celyad Oncology has a current market capitalization of EUR 16.8 mn and approximately EUR 387.744 worth of Celyad Oncology was traded on exchanges in the last 24 hours. Since last month end, Celyad Oncology has traded -10.04 % down. Simple moving average of last 200 days is at EUR 0.27. The highest price of past 52 weeks was recorded at EUR 0.65 on 02/17/2026. 52 weeks low was at EUR 0.16 on 12/30/2025.
Here is how related stocks have performed in the past 24 hours:
Coil (ALCOI.PA) traded flat 0 % and now trades at EUR 1.19. Current market capitalisation for Coil is EUR 6.4 mn.
Bonyf (MLBON.PA) traded flat 0 % and now trades at EUR 1.9. Current market capitalisation for Bonyf is EUR 1.1 mn.
Diegem Kennedycert (DIEG.BR) traded down -8.71 % and now trades at EUR 92.2. Current market capitalisation for Diegem Kennedycert is EUR 9.4 mn. Current price/earnings ratio for Diegem Kennedycert is 10.43.
Mdxhealth (O6C1.F) traded down -60 % and now trades at EUR 0. Current market capitalisation for Mdxhealth is EUR 190.8 k.
Photonike Capital (MLPHO.PA) traded up 6.06 % and now trades at EUR 0.07. Current market capitalisation for Photonike Capital is EUR 7.4 mn.
About Celyad Oncology
Celyad Oncology SA is a bio-pharmaceutical company that specializes in CAR-T cell therapy. The company is developing groundbreaking technologies aimed at treating severe diseases with poor prognosis, particularly cancer. As a global player, Celyad Oncology serves customers worldwide. You can find more information about their activities and offerings on their website at www.celyad.com . The company’s stock is traded on the NYSE Euronext Brussels.